Home-Based Phototherapy as Effective as Office-Based for Psoriasis
By Elana Gotkine HealthDay Reporter
MONDAY, Sept. 30, 2024 -- For plaque or guttate psoriasis, home-based narrowband ultraviolet B phototherapy is as effective as office-based phototherapy, according to a study published online Sept. 25 in JAMA Dermatology to coincide with the annual meeting of the European Academy of Dermatology and Venereology, held from Sept. 25 to 28 in Amsterdam.
Joel M. Gelfand, M.D., from the University of Pennsylvania in Philadelphia, and colleagues conducted an open-label, parallel-group, noninferiority randomized clinical trial involving participants aged 12 years or older with plaque or guttate psoriasis who were candidates for home- and office-based phototherapy.
Overall, 393 participants received home-based phototherapy and 390 received office-based phototherapy. Ninety-three of the patients (11.9 percent) were receiving systemic treatment. The researchers found that the mean Physician Global Assessment (PGA) was 2.7 and Dermatology Life Quality Index (DLQI) was 12.2 at baseline. At week 12, 32.8 and 25.6 percent, respectively, of those receiving home-based phototherapy and office-based phototherapy achieved clear/almost clear skin, and 52.4 and 33.6 percent, respectively, achieved a DLQI of 5 or lower. In the overall population and across all skin phototypes, home-based phototherapy was noninferior to office-based phototherapy for PGA and DLQI. Compared with office-based phototherapy, home-based phototherapy was associated with better treatment adherence (51.4 versus 15.9 percent of patients), a lower burden of indirect cost to patients and more episodes of persistent erythema (5.9 versus 1.2 percent of treatments).
"Efforts should be made to make these safe, effective, and relatively inexpensive treatment options more available to patients in the modern era of psoriasis therapeutics," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
Psoriatic Arthritis Tied to Delays in Diagnosis Compared With Rheumatoid Arthritis
WEDNESDAY, April 30, 2025 -- Patients with psoriatic arthritis (PsA) have delays in diagnosis compared with those with rheumatoid arthritis (RA), according to a study published...
Declining Childhood Vaccination May Increase Risk for Vaccine-Preventable Infections
WEDNESDAY, April 30, 2025 -- Declining childhood vaccination rates may increase outbreaks of eliminated vaccine-preventable infections within the United States, leading to a...
AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer
TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.